Sanofi is jet­ti­son­ing its in­fec­tious dis­ease unit to Evotec — hand­ing over cash, staff and a pipeline

Sanofi is spin­ning out its in­fec­tious dis­ease re­search unit to Evotec, the Ger­man con­tract de­vel­op­ment or­ga­ni­za­tion known for its deal savvi­ness. And the Paris-based phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER